首页 > 市场调查报告书 > 製药

自体免疫疾病

市场调查报告书

商品编码

1578279

全球自体免疫疾病诊断市场研究报告 - 2024 年至 2032 年行业分析、规模、份额、成长、趋势和预测

Global Autoimmune Disease Diagnostics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年09月01日 | 出版商:

Value Market Research | 英文 231 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球自体免疫疾病诊断市场需求预计将从 2023 年的 132 亿美元达到 2032 年近 193.5 亿美元的市场规模，2024-2032 年研究期间复合年增长率为 4.34%。

免疫系统可以保护身体免受许多细菌、病毒感染和其他疾病的侵害。自体免疫疾病是体内发生的一种不寻常的免疫反应。自体免疫疾病会降低人体抵抗外来颗粒的能力，进而导致攻击自身组织。自体免疫疾病在女性中比男性更常见。克罗恩病、类风湿性关节炎、发炎性肠道疾病、多发性硬化症、系统性红斑狼疮是自体免疫疾病的一些例子。一些医疗中心有许多商业测试可用于诊断自体免疫疾病。

市场动态

由于政府资助的增加以及诊所和诊断中心的合作，全球自体免疫疾病诊断市场预计将成长。除此之外，类风湿性关节炎、格雷夫兹病和桥本甲状腺病等疾病发生率的上升也推动了市场的成长。此外，对各种自体免疫疾病的认识、医学领域的进步、实验室技术的改进等也推动了需求。然而，假阳性结果的高可能性和诊断测试结果的缓慢週转时间可能会阻碍市场成长。此外，新兴市场的发展以及用于疾病预后的新型生物标记的进步可能会为市场成长提供新的机会。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球自体免疫疾病诊断市场的各个细分市场进行了包容性评估。自体免疫疾病诊断产业的成长和趋势为这项研究提供了整体方法。

市场区隔

自体免疫疾病诊断市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人口统计数据以及即将到来的机会。

按测试类型

抗核抗体测试
自体抗体测试
全血球计数 (CBC)
综合代谢组
C反应蛋白（CRP）测试
红血球沉降速率 (ESR)
尿液分析
其他的

依疾病类型

格雷夫兹病
桥本氏甲状腺
多发性硬化症
类风湿关节炎
系统性红斑狼疮（狼疮）
1 型糖尿病
其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲自体免疫疾病诊断市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。自体免疫疾病诊断市场的主要参与者包括Abbott Laboratories Inc.、Beckman Coulter Inc.、BioMeRieux SA、Bio-Rad Laboratories、F. Hoffmann-La、Roche Ltd.、Inova Diagnostics Inc.、Quest Diagnostics、SQI Diagnostics Inc .。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 8 章：自体免疫疾病诊断公司的竞争格局

自体免疫疾病诊断市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 9 章：公司简介

顶级公司市占率分析
市场集中度
Abbott Laboratories Inc.

公司概况
公司收入
产品
最新动态

Beckman Coulter Inc.

公司概况
公司收入
产品
最新动态

BioMeRieux SA

公司概况
公司收入
产品
最新动态

Bio-Rad Laboratories

公司概况
公司收入
产品
最新动态

F. Hoffmann-La

公司概况
公司收入
产品
最新动态

Roche Ltd.

公司概况
公司收入
产品
最新动态

Inova Diagnostics Inc.

公司概况
公司收入
产品
最新动态

Quest Diagnostics

公司概况
公司收入
产品
最新动态

SQI Diagnostics Inc.

公司概况
公司收入
产品
最新动态

Siemens Healthcare

公司概况
公司收入
产品
最新动态

註 - 在公司概况中，财务详细资料和最新进展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR11214429

The global demand for Autoimmune Disease Diagnostics Market is presumed to reach the market size of nearly USD 19.35 Billion by 2032 from USD 13.2 Billion in 2023 with a CAGR of 4.34% under the study period 2024-2032.

The immune system offers protection to the body from many bacterial, viral infections, and other diseases. The autoimmune disorder is an unusual immune response occurring in the body. Autoimmune diseases reduce the body's ability to fight with the foreign particles resulting in attacking own body's tissues. The autoimmune disease is more common in women than men. Crohn's disease, rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis, systemic lupus erythematosus are some examples of autoimmune diseases. There are many tests commercially available at several healthcare centers to diagnose autoimmune disorders.

MARKET DYNAMICS

The global autoimmune disease diagnostics market is expected to grow due to increased government funding, a collaboration of clinics and diagnostics centers. In addition to this, the rise in the incidence of diseases such as rheumatoid arthritis, Graves, and Hashimoto's thyroid disease drives the growth of the market. Further, awareness about the various autoimmune diseases, advancements in medical fields, improved laboratory techniques, and others are also propelling the demand. However, high chances of false-positive results and slow turnaround time for diagnostic test results may hamper the market growth. Moreover, the developments in an emerging market, advancement in novel biomarkers for the prognosis of diseases are likely to offer new opportunities in market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Autoimmune Disease Diagnostics. The growth and trends of Autoimmune Disease Diagnostics industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Autoimmune Disease Diagnostics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Test Type

Antinuclear Antibody Test
Autoantibody Test
Complete Blood Count (CBC)
Comprehensive Metabolic Panel
C-reactive Protein (CRP) Test
Erythrocyte Sedimentation Rate (ESR)
Urinalysis
Others

By Disease Type

Graves' Disease
Hashimoto's Thyroid its
Multiple Sclerosis
Rheumatoid Arthritis
SLE (Lupus)
Type 1 Diabetes
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Autoimmune Disease Diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Autoimmune Disease Diagnostics market include Abbott Laboratories Inc., Beckman Coulter Inc., BioMeRieux SA, Bio-Rad Laboratories, F. Hoffmann-La, Roche Ltd., Inova Diagnostics Inc., Quest Diagnostics, SQI Diagnostics Inc. Siemens Healthcare Among Others. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. AUTOIMMUNE DISEASE DIAGNOSTICS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Test Type
- 3.7.2 Market Attractiveness Analysis By Disease Type
- 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ANALYSIS BY TEST TYPE

5.1. Overview By Test Type
5.2. Historical and Forecast Data Analysis By Test Type
5.3. Antinuclear Antibody Test Historic and Forecast Sales By Regions
5.4. Autoantibody Test Historic and Forecast Sales By Regions
5.5. Complete Blood Count (CBC) Historic and Forecast Sales By Regions
5.6. Comprehensive Metabolic Panel Historic and Forecast Sales By Regions
5.7. C-reactive Protein (CRP) Test Historic and Forecast Sales By Regions
5.8. Erythrocyte Sedimentation Rate (ESR) Historic and Forecast Sales By Regions
5.9. Urinalysis Historic and Forecast Sales By Regions
5.10. Others Historic and Forecast Sales By Regions

6. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ANALYSIS BY DISEASE TYPE

6.1. Overview By Disease Type
6.2. Historical and Forecast Data Analysis By Disease Type
6.3. Graves' Disease Historic and Forecast Sales By Regions
6.4. Hashimoto's Thyroid its Historic and Forecast Sales By Regions
6.5. Multiple Sclerosis Historic and Forecast Sales By Regions
6.6. Rheumatoid Arthritis Historic and Forecast Sales By Regions
6.7. SLE (Lupus) Historic and Forecast Sales By Regions
6.8. Type 1 Diabetes Historic and Forecast Sales By Regions
6.9. Others Historic and Forecast Sales By Regions

7. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1 Overview, Historic and Forecast Data Sales Analysis
- 7.3.2 North America By Segment Sales Analysis
- 7.3.3 North America By Country Sales Analysis
- 7.3.4 United States Sales Analysis
- 7.3.5 Canada Sales Analysis
- 7.3.6 Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1 Overview, Historic and Forecast Data Sales Analysis
- 7.4.2 Europe By Segment Sales Analysis
- 7.4.3 Europe By Country Sales Analysis
- 7.4.4 United Kingdom Sales Analysis
- 7.4.5 France Sales Analysis
- 7.4.6 Germany Sales Analysis
- 7.4.7 Italy Sales Analysis
- 7.4.8 Russia Sales Analysis
- 7.4.9 Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1 Overview, Historic and Forecast Data Sales Analysis
- 7.5.2 Asia Pacific By Segment Sales Analysis
- 7.5.3 Asia Pacific By Country Sales Analysis
- 7.5.4 China Sales Analysis
- 7.5.5 India Sales Analysis
- 7.5.6 Japan Sales Analysis
- 7.5.7 South Korea Sales Analysis
- 7.5.8 Australia Sales Analysis
- 7.5.9 South East Asia Sales Analysis
- 7.5.10 Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1 Overview, Historic and Forecast Data Sales Analysis
- 7.6.2 Latin America By Segment Sales Analysis
- 7.6.3 Latin America By Country Sales Analysis
- 7.6.4 Brazil Sales Analysis
- 7.6.5 Argentina Sales Analysis
- 7.6.6 Peru Sales Analysis
- 7.6.7 Chile Sales Analysis
- 7.6.8 Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1 Overview, Historic and Forecast Data Sales Analysis
- 7.7.2 Middle East & Africa By Segment Sales Analysis
- 7.7.3 Middle East & Africa By Country Sales Analysis
- 7.7.4 Saudi Arabia Sales Analysis
- 7.7.5 UAE Sales Analysis
- 7.7.6 Israel Sales Analysis
- 7.7.7 South Africa Sales Analysis
- 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE AUTOIMMUNE DISEASE DIAGNOSTICS COMPANIES

8.1. Autoimmune Disease Diagnostics Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9. COMPANY PROFILES OF AUTOIMMUNE DISEASE DIAGNOSTICS INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. Abbott Laboratories Inc.
- 9.3.1 Company Overview
- 9.3.2 Company Revenue
- 9.3.3 Products
- 9.3.4 Recent Developments
9.4. Beckman Coulter Inc.
- 9.4.1 Company Overview
- 9.4.2 Company Revenue
- 9.4.3 Products
- 9.4.4 Recent Developments
9.5. BioMeRieux SA
- 9.5.1 Company Overview
- 9.5.2 Company Revenue
- 9.5.3 Products
- 9.5.4 Recent Developments
9.6. Bio-Rad Laboratories
- 9.6.1 Company Overview
- 9.6.2 Company Revenue
- 9.6.3 Products
- 9.6.4 Recent Developments
9.7. F. Hoffmann-La
- 9.7.1 Company Overview
- 9.7.2 Company Revenue
- 9.7.3 Products
- 9.7.4 Recent Developments
9.8. Roche Ltd.
- 9.8.1 Company Overview
- 9.8.2 Company Revenue
- 9.8.3 Products
- 9.8.4 Recent Developments
9.9. Inova Diagnostics Inc.
- 9.9.1 Company Overview
- 9.9.2 Company Revenue
- 9.9.3 Products
- 9.9.4 Recent Developments
9.10. Quest Diagnostics
- 9.10.1 Company Overview
- 9.10.2 Company Revenue
- 9.10.3 Products
- 9.10.4 Recent Developments
9.11. SQI Diagnostics Inc.
- 9.11.1 Company Overview
- 9.11.2 Company Revenue
- 9.11.3 Products
- 9.11.4 Recent Developments
9.12. Siemens Healthcare
- 9.12.1 Company Overview
- 9.12.2 Company Revenue
- 9.12.3 Products
- 9.12.4 Recent Developments